Trial intelligence / Profile preview

Leuplin SR 11.25 mg long-term use survey in premenopausal breast cancer

jRCT1080222466

Sponsor
Takeda
Start
Apr 2014
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Open-label, single-arm trial of leuprolide in breast cancer, sponsored by Takeda.

02

Drugs

leuprolide
03

Conditions

breast cancer

Beyond the preview

Go deeper on jRCT1080222466.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080222466.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call